| Reunion | | |
Incidents of all cancers (age-standardized rate, per 100,000 population) | 212.5 (2020) [63/185countries] | | |
Incidents of cancer at bladder (age-standardized rate, per 100,000 population) | 4.8 (2020) [79/184countries] | | |
Incidents of cancer at brain, central nervous system (age-standardized rate, per 100,000 population) | 3.2 (2020) [81/181countries] | | |
Incidents of cancer at breast (age-standardized rate, per 100,000 population) | 59.6 (2020) [56/185countries] | | |
Incidents of cancer at cervix uteri (age-standardized rate, per 100,000 population) | 10.3 (2020) [127/185countries] | | |
Incidents of cancer at colorectum (age-standardized rate, per 100,000 population) | 40.2 (2020) [53/185countries] | | |
Incidents of cancer at corpus uteri (age-standardized rate, per 100,000 population) | 6.7 (2020) [101/183countries] | | |
Incidents of cancer at gallbladder (age-standardized rate, per 100,000 population) | 1.5 (2020) [21/177countries] | | |
Incidents of cancer at kidney (age-standardized rate, per 100,000 population) | 4.3 (2020) [61/182countries] | | |
Incidents of cancer at larynx (age-standardized rate, per 100,000 population) | 2.6 (2020) [42/184countries] | | |
Incidents of cancer at leukaemia (age-standardized rate, per 100,000 population) | 6.4 (2020) [54/185countries] | | |
Incidents of cancer at lip and oral cavity (age-standardized rate, per 100,000 population) | 4.6 (2020) [21/183countries] | | |
Incidents of cancer at liver (age-standardized rate, per 100,000 population) | 7.6 (2020) [52/185countries] | | |
Incidents of cancer at lung (age-standardized rate, per 100,000 population) | 24.8 (2020) [47/185countries] | | |
Incidents of cancer at skin (age-standardized rate, per 100,000 population) | 3.4 (2020) [102/183countries] | | |
Incidents of cancer at multiple myeloma (age-standardized rate, per 100,000 population) | 2.5 (2020) [51/178countries] | | |
Incidents of cancer at nasopharynx (age-standardized rate, per 100,000 population) | 0.2 (2020) [147/172countries] | | |
Incidents of cancer at lymphoma (age-standardized rate, per 100,000 population) | 7.2 (2020) [74/184countries] | | |
Incidents of cancer at oesophagus (age-standardized rate, per 100,000 population) | 3.6 (2020) [51/183countries] | | |
Incidents of cancer at oropharynx (age-standardized rate, per 100,000 population) | 2.8 (2020) [10/173countries] | | |
Incidents of cancer at ovary (age-standardized rate, per 100,000 population) | 6.0 (2020) [100/185countries] | | |
Incidents of cancer at pancreas (age-standardized rate, per 100,000 population) | 7.2 (2020) [42/184countries] | | |
Incidents of cancer at prostate (age-standardized rate, per 100,000 population) | 61.9 (2020) [46/185countries] | | |
Incidents of cancer at stomach (age-standardized rate, per 100,000 population) | 9.5 (2020) [45/184countries] | | |
Incidents of cancer at testis (age-standardized rate, per 100,000 population) | 2.7 (2020) [60/174countries] | | |
Incidents of cancer at thyroid (age-standardized rate, per 100,000 population) | 3.5 (2020) [101/184countries] | | |